European Healthtech startup funding raised during H1 2017.
In H1 2017, 215 European Healthtech companies raised a combined €1.8B across 229 funding rounds, up 64.6% versus H1 2016. Israel led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
16 exits · €362M disclosed.
| Zur Rose | IPO | Jan 2017 | €184M |
| Europa Apotheek | Acquisition | Feb 2017 | €126M |
| Crospon | Acquisition | May 2017 | €41M |
| Evoxx Technologies | Acquisition | Feb 2017 | €7.7M |
| Biotechware | Acquisition | May 2017 | €2.0M |
| Cipla Croatia | Acquisition | May 2017 | €1.0M |
| €56M |
| Simba Sleep | Series B | Apr 2017 | €47M |
| Xeltis | Series C | Apr 2017 | €45M |
| Market Logic | Other | May 2017 | €45M |
| Breath Therapeutics | Series A | Mar 2017 | €44M |
| Impulse Dynamics | Other | May 2017 | €41M |
| Vivet Therapeutics | Series A | May 2017 | €38M |
| StarLeaf | Other | May 2017 | €37M |
| Doctolib | Other | Apr 2017 | €35M |
| Medlumics | Series B | Mar 2017 | €34M |
| ALung Technologies | Series C | Apr 2017 | €34M |
| Atlas Genetics | Series D+ | Jan 2017 | €32M |
